InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: Pharmacydude post# 27454

Monday, 05/12/2014 3:16:40 PM

Monday, May 12, 2014 3:16:40 PM

Post# of 426562
Lovaza was rejected for "ANCHOR" indication based on study result, however the official, FDA approved label contains "14.2 Other Clinical Experience" details the faild study. So it is not a compromise for Vascepa.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News